RSV is a labile paramyxovirus that produces a characteristic fusion of human cells in tissue culture--the syncytial effect. Two subtypes, A and B, have been identified. Subtype B are characterized as the asymptomatic strains of the virus. The more severe clinical illnesses involve Subtype A strains.
Synonyms: RSV Fusion
Application: Indirect immunofluorescence. Final working dilutions must be determined by end user.
Legal Information: CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany